Artelo Biosciences

Artelo Biosciences is a clinical-stage biopharmaceutical company listed on NASDAQ under the ticker symbol ARTL. The company focuses on the development of innovative therapies for metabolic and neurodegenerative diseases, leveraging advanced research in drug discovery and molecular biology. Artelo's pipeline includes multiple candidates in preclinical and clinical phases, targeting conditions such as obesity, diabetes, and Parkinson's disease. With a strong emphasis on scientific rigor and patien